文献速递甲状腺疾病

Notch双等位基因变异在先天性甲状腺功能减退症中的大规模筛查

First large-scale screening of Notch biallelic variants implicates novel candidate genes in congenital hypothyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究对781例中国先天性甲状腺功能减退症(CH)患者行全外显子测序,在417例已知基因未解病例中筛查77个Notch通路基因,发现21例携带11个Notch通路基因的双等位基因变异,斑马鱼敲低实验支持其致病性;Notch变异患者初始FT4较高但左甲状腺素需求量显著高于DUOX2患者。

要点

  • Notch通路变异可能解释约5%的遗传未解CH病例。
  • Notch变异患者初始FT4较高,但左甲状腺素需求量显著高于DUOX2患者。
  • 斑马鱼敲低实验显示甲状腺球蛋白表达降低、形态异常、tsh升高和T4降低。

核心结论

  • Notch通路变异可能贡献约5%的遗传未解CH,多个通路组分变异共同损害甲状腺功能。

研究设计与样本

  • 对781例无亲缘关系的中国CH患者行全外显子测序,其中364例已知致病基因阳性,剩余417例筛查77个Notch信号通路基因,并行斑马鱼功能验证。

主要发现

  • 在21例患者中鉴定出11个Notch通路基因(NEURL1、CNTN6、NOTCH3、DTX1、DVL1、DTX2、ATXN1、SPEN、CTBP2、NCOR2、MAMLD1)的双等位基因变异。
  • 斑马鱼敲低实验显示甲状腺球蛋白表达降低、形态异常、tsh水平升高和T4降低,支持这些基因的潜在致病作用。
  • Notch变异患者初始FT4较高,但左甲状腺素需求量显著高于267例DUOX2患者。

关键数值与推荐

  • Notch通路变异可能占遗传未解CH的约5%。
  • Notch变异患者尽管初始表现较轻,但可能需要更高剂量的激素替代治疗。

临床怎么用

  • 对遗传未解的CH患者可考虑Notch通路基因筛查。
  • Notch变异患者应关注左甲状腺素剂量需求可能较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Congenital hypothyroidism (CH) is a major preventable cause of developmental and cognitive impairment. Current genetic testing identifies causative variants for only half of cases, leaving the majority without a molecular diagnosis. Although animal studies implicate Notch signaling in thyroid development, its role in human CH remains unexplored. OBJECTIVE: To investigate whether Notch pathway variants contribute to genetically unexplained CH. DESIGN: Genetic screening using whole-exome sequencing with zebrafish functional validation. SETTING: Endocrinology outpatient clinic at Shanghai Ninth People's Hospital. PATIENTS OR OTHER PARTICIPANTS: A total of 781 unrelated Chinese patients with CH. After identifying variants in 21 known causative genes in 364 patients, the remaining 417 unsolved cases were screened for variants in 77 Notch signaling pathway genes. MAIN OUTCOME MEASURE(S): Identification of biallelic Notch pathway variants; functional validation through zebrafish morpholino knockdown experiments assessing thyroid morphology and hormone production; clinical phenotype including thyroid function parameters, thyroid morphology, and levothyroxine dosage requirements; comparison with 267 DUOX2 patients. RESULTS: We identified biallelic variants in 11 Notch pathway genes (NEURL1, CNTN6, NOTCH3, DTX1, DVL1, DTX2, ATXN1, SPEN, CTBP2, NCOR2, MAMLD1) in 21 patients. Zebrafish knockdown provided functional support for the potential pathogenic role of these genes, showing reduced thyroglobulin expression, abnormal morphology, elevated tsh levels, and decreased T4. Notch-variant patients showed higher initial FT4 but required significantly higher levothyroxine doses than DUOX2 patients. CONCLUSION: Notch pathway variants may contribute to approximately 5% of genetically unexplained CH. Variants across multiple pathway components collectively impair thyroid function. These findings suggest a potential expansion of CH genetic architecture and suggest that Notch-variant patients may require enhanced hormone replacement despite milder initial presentation, warranting pathway-specific screening.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wu FY, Wu CY, Wang Z, et al. First large-scale screening of Notch biallelic variants implicates novel candidate genes in congenital hypothyroidism. J Clin Endocrinol Metab. 2026. PMID: 42192612. doi:10.1210/clinem/dgag208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。